Skip to contentD
DNA X, Inc.
D
SONMDNA X, Inc. Q1 2025 · 10-Q
Revenue$16.72M$16.72M+83.4% vs Q1 2024 Net Income$458.00K$458.00KN/M vs Q1 2024 EPS Diluted$1.41$1.41N/M vs Q1 2024 Gross Profit$8,356,000+187.9% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
DNA X, Inc. · CIK 1178697 · Engraved from SEC EDGAR
Operating Cash Flow-$9,606,000N/M Margins · derivedGross margin50.0%+18.1 pt vs Q1 2024
Operating margin3.9%+33.3 pt vs Q1 2024
Net margin2.7%+34.6 pt vs Q1 2024
ended Mar 31, 2025 · filed May 12, 2025 · 42 d after period end